510(k) K162526

Creatine Kinase-MB by Roche Diagnostics — Product Code JHW

K162526 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Creatine Kinase-MB". The FDA issued a decision of Substantially Equivalent on May 26, 2017. The device falls under product code JHW (U.V. Method, Cpk Isoenzymes), a Class II device regulated under 21 CFR 862.1215. Roche Diagnostics has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 26, 2017
Date Received
September 9, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
U.V. Method, Cpk Isoenzymes
Device Class
Class II
Regulation Number
862.1215
Review Panel
CH
Submission Type